Trends in Australian attitudes towards the availability of take-home naloxone: Evidence from the National Drug Strategy Household Survey.  McNeilage AG, Roxburgh A, Nielsen S, Picco L.  Int J Drug Policy. 2026 Jun 4:105354. doi: 10.1016/…

Data from the European Syringe Collection and Analysis Project Enterprise (ESCAPE): data explorer, analysis and key 2024 findings Background and introduction While evidence from drug treatment centres suggests that injecting drug use is declining…

Prevalence and predictors of patient-directed discharge in patients with opioid use disorder.  Angelova Y, Kwak HR, Zimmerman P, Thearle M, Gardner W, Mirza O, Cheung S.  Gen Hosp Psychiatry. 2026 May 7;101:1-6. doi: 10.1016/j.genhosppsy…

Zürich. Studienteilnehmer:innen für wissenschaftliche Studie gesucht - Untersuchung von kognitiven Begleiterscheinungen des nicht-medizinischen Opioidkonsums (NMPOU-Studie)  Ziel der Studie: Wir möchten herausfinden, wie sich der regelmässige…

Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study Dupouy J, Druel V, Verges Y et al. The Lancet Public Health, 11, e449-e456 https://www.thelancet.com/journals/lanpub/article/PIIS2468-…

Projected Outcomes of Reducing Federal Funding for Syringe Service Programs via Executive Order.  Fetters KB, Padmanabhan P, Yamkovoy K, et al.  JAMA Netw Open. 2026;9(6):e2619402. doi:10.1001/jamanetworkopen.2026.19402 https://jamanetw…